Main
Сlinical Trials
Dogs & Cats
- Comparative Medicine and Veterinary Research
Elenagen
IP
Publications
Investors
- One-pager
- Slide presentation
Team
News
- Company news
- In the news
Legal

Contact us

Please contact us at:

Corporate Mission

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.
CureLab Oncology is committed to creating a family of revolutionary
therapies for oncology patients in order to help prolong their lives.

Our Lead Product

Our lead product, Elenagen, is a plasmid (supercoiled circular DNA) encoding gene p62/SQSTM1. Elenagen reverses tumor grade, changes tumor microenvironment, enhances the anti-cancer effects of other therapies (e.g. chemotherapy), mitigates chronic inflammation, and stimulates an immune attack on the tumor.

Clinical Trials

The CureLab Oncology team has completed its international Phase I/IIa Clinical Trials of Elenagen.
The vaccine demonstrated a high degree of safety as well as clinical benefits in a number of patients.
We are now preparing Phase II Clinical Trials within the US.

Contact us

E-mail:

info@curelab.com,

Call us:

1-609-841-1201

177 HUNTINGTON
AVE FL 17
BOSTON MA 02115-3156